Recently, CareFusion agreed to settle an FCA case with the Justice Department for $3.3 million while admitting to selling devices not approved or cleared by the FDA. While the full set of facts remains under seal, it appears that CareFusion’s liability stems from faulty representations provided to the company by the original device manufacturer.
Read the full article in the September issue of Policy and Medicine Compliance Update https://complianceupdate.policymed.com/september-2019-policy-medicine-compliance-update/